The SPINT2 gene has been proposed to act as a putative tumor suppressor in several cancer entities, including gastric cancer (45), glioblastoma (46), medulloblastoma (47), melanoma (48), and renal cell carcinoma (49). Here, SPINT2 is linked to gastric cancer.